How blood chemicals from malaria patients affect mosquitoes and transmission
Biogenic amines, malaria and manipulation of mosquito physiology and behavior.
This project looks at whether changes in blood levels of histamine and serotonin during malaria make mosquitoes more likely to pick up and spread the parasite, which matters for people at risk of malaria.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Idaho NIH-funded |
| Lab location | 1 site (Moscow, United States) |
| Project ID | NIH-11142647 on NIH RePORTER |
What this research studies
From a patient's perspective, researchers are exploring how two blood chemicals (histamine and serotonin) that change during severe malaria affect mosquito biology and their ability to carry and pass on malaria. They will feed mosquitoes blood containing realistic amounts of these chemicals and then measure parasite infection success, biting behavior, egg laying, survival, and other life-history traits. The work uses the human malaria parasite Plasmodium falciparum and a mouse parasite model to compare effects and will probe gut-brain signaling pathways in the mosquito. The goal is to connect clinical blood changes seen in malaria patients to mosquito traits that influence transmission.
Who could benefit from this research
Good fit: People recently diagnosed with severe malaria or willing to donate blood samples with measured histamine and serotonin levels would be the most relevant participants for sample collection.
Not a fit: People without malaria or those living far from malaria transmission zones are unlikely to receive direct benefit from this work.
Why it matters
Potential benefit: If successful, this could point to novel ways to reduce malaria transmission by targeting how mosquitoes respond to human blood chemicals.
How similar studies have performed: This is a relatively novel approach linking human blood amine changes to mosquito biology; prior evidence connects amine changes to disease but direct transmission-focused experiments are limited and exploratory.
Where this research is happening
Moscow, United States
- University of Idaho — Moscow, United States (Active)
Researchers
- Principal investigator: Luckhart, Shirley — University of Idaho
- Study coordinator: Luckhart, Shirley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.